Information on APRILD
Basic details
Name: APRIL deficiency | Acronym: APRILD
Alt. names: Autosomal recessive TNFSF13 loss-of-function
Gene: TNFSF13 | MOI: Autosomal recessive | Mechanism of action: Loss of Function
No. of cases in DB: 1 | First reported in: 2020
Last updated on: 2023-10-22 21:20:16 by Xiao P. Peng
OMIM:
Orphanet: -
MONDO: -
DOID: -
ClinGen:
Description
Only 1 patient has been reported in the literature thus far - Yeh et al. (2020) identified a a nullomorphic homozygous TNFSF13 frameshift mutation in a 55-year-old Japanese man presenting with history of mild sinorespiratory infections, steroid-responsive alopecia areata and later development of small lung nodules. On labs, he had incidentally found, progressive hypogammaglobulinemia and reduced memory B cells, but normal overall T- and B-cell counts and proliferative responses (PMID: 32298700).
Management
For his humoral immunodeficiency, the above patient was started and maintained on lifetime immunoglobulin replacement, beginning with intravenous and then later switching to subcutaneous administration - this appeared to improve his infection susceptibility (PMID: 32298700). His alopecia areata was successfully treated with prednisolone for 3 months. His sinorespiratory infections were treated with antibiotics as needed. No other forms of management have been discussed in the literature.
1 reported cases added to GenIA
AD: Age at genetic diagnosis; AFM: age at first manifestation; PMID: PubMed ID; GRID: GenIA reference ID (ref. not in PubMed).
Summary of clinical findings
[Considering only Definitive and Possible cases]
Summary of treatment outcomes
[Considering only Definitive and Possible cases]
Treatment ⓘ | Responses & clinical indications |
---|